Equity Overview
Price & Market Data
Price: $2.21
Daily Change: $0.00 / 0.00%
Daily Range: $2.15 - $2.40
Market Cap: $9,943,698
Daily Volume: 43,152
Performance Metrics
1 Week: -5.15%
1 Month: -21.35%
3 Months: -20.22%
6 Months: -42.89%
1 Year: -28.71%
YTD: -20.22%
Company Details
Employees: 24
Sector: Health technology
Industry: Pharmaceuticals: major
Country: Israel
Details
BioLineRx Ltd., a commercial stage biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases. The company's pipeline includes APHEXDA (motixafortide), a peptide that is in Phase 1 clinical trial for the treatment of sickle cell disease, and Phase 2b clinical trial for the treatment of pancreatic cancer, as well as completed Phase 3 clinical trial for the treatment of multiple myeloma. It develops BL-5010, a pen-like applicator containing an acidic aqueous solution for the non-surgical removal of skin lesions. BioLineRx Ltd. was incorporated in 2003 and is headquartered in Hevel Modi'in, Israel.